home / stock / lexxw / lexxw quote
Last: | $1.10 |
---|---|
Change Percent: | 0.0% |
Open: | $1.05 |
Close: | $1.10 |
High: | $1.1 |
Low: | $1.05 |
Volume: | 15,606 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.1 | $1.05 | $1.1 | $1.1 | $1.05 | 15,606 | 07-22-2024 |
$1.05 | $1.02 | $1.05 | $1.3 | $1.02 | 17,763 | 07-19-2024 |
$1.03 | $1.05 | $1.03 | $1.05 | $1.03 | 570 | 07-18-2024 |
$1.05 | $1.01 | $1.05 | $1.05 | $1.01 | 634 | 07-17-2024 |
$1.0169 | $0.9003 | $1.0169 | $1.0169 | $0.9003 | 367 | 07-16-2024 |
$1 | $0.903 | $1 | $1.05 | $0.903 | 611 | 07-15-2024 |
$1.01 | $0 | $1.01 | $0 | $0 | 1 | 07-12-2024 |
$1.01 | $0.85 | $1.01 | $1.01 | $0.85 | 294 | 07-11-2024 |
$1.05 | $1.03 | $1.05 | $1.05 | $0.9 | 11,260 | 07-10-2024 |
$1.07 | $1.69 | $1.07 | $1.69 | $0.8 | 18,269 | 07-09-2024 |
$1.15 | $1.15 | $1.15 | $1.15 | $1.15 | 2,213 | 07-08-2024 |
$1.19 | $1 | $1.19 | $1.19 | $0.99 | 3,400 | 07-05-2024 |
$1.1 | $0.98 | $1.1 | $1.1 | $0.98 | 339 | 07-04-2024 |
$1.1 | $0.98 | $1.1 | $1.1 | $0.98 | 339 | 07-03-2024 |
$1 | $0.845 | $1 | $1 | $0.845 | 636 | 07-02-2024 |
$0.999 | $0.98 | $0.999 | $0.999 | $0.98 | 544 | 07-01-2024 |
$0.8063 | $0.8736 | $0.8063 | $1.6584 | $0.7507 | 8,786 | 06-28-2024 |
$0.8501 | $1.4499 | $0.8501 | $1.4499 | $0.8501 | 16,803 | 06-27-2024 |
$1.3 | $1.3 | $1.3 | $1.3 | $1.3 | 1,700 | 06-26-2024 |
$1.05 | $1.03 | $1.05 | $1.4 | $1.02 | 1,555 | 06-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Lexaria Bioscience Corp. Warrant Company Name:
LEXXW Stock Symbol:
NASDAQ Market:
Lexaria Bioscience Corp. Warrant Website:
Lexaria Bioscience (NASDAQ: LEXX, LEXXW) , a global innovator in drug delivery platforms, today announced the receipt of interim results from the first four weeks of dosing in its ongoing diabetes animal study WEIGHT-A24-1. The company noted that the results have already produced several notewort...
(TheNewswire) DehydraTECH appears to work with a second GLP-1 drug – liraglutide DehydraTECH appears to be working with semaglutide both with and without SNAC technology DehydraTECH-CBD is showing strong apparent performance relative to GLP-1 D...
Lexaria Bioscience (NASDAQ: LEXX, LEXXW) , a global innovator in drug-delivery platforms, is preparing for growth by executing a strategic growth plan. A key element of the plan includes expanding the company’s management team to enable efficient handling of a greater workload of projects ...